BioSpace News Archive

3D (Three-Dimensional) Imaging Market Analysis, Statistics, Revenue, Demand and Trend Analysis Research Report by 2030

Rising demand for consumer electronics and increasing preference for high-resolution images in gaming industry are driving three-dimensional (3D) imaging market revenue growth.

March 16, 2022
·
8 min read
Mobile Heart Monitoring Devices Market Trends, Revenue, Key Players, Growth, Share and Forecast Till 2028

The report provides details about market size, market restraints, drivers, challenges, growth opportunities, and top companies in the market.

March 16, 2022
·
6 min read
Animal Health Market Size to Reach USD 79.29 Billion in 2028, Says Reports and Data

Increasing adoption of companion animals across the globe, high demand for animal-based products such as meat, eggs, and fish, improving animal healthcare infrastructure, and increasing number of online retail stores offering animal healthcare products are key factors fueling global market growth.

March 16, 2022
·
8 min read
Ophthalmic Ultrasound System Market Insights, Future Trends, On-going Demand, Opportunities, Segmentation, and Forecast till 2028

The data has been collected through extensive primary and secondary research and is validated by experts in the industry.

March 16, 2022
·
6 min read
Drug Development

LYNPARZA® (olaparib) Reduced Risk of Death by 32% in Patients With Germline BRCA-Mutated, HER2-Negative High-Risk Early Breast Cancer in Phase 3 OlympiA Trial

AstraZeneca and Merck, known as MSD outside the United States and Canada, announced additional positive results from the Phase 3 OlympiA trial.

March 16, 2022
·
23 min read
Biotech Beach

Regen BioPharma, Inc. Responds to Numerous Requests for Updates on its Intellectual Property (IP) Portfolio

Regen BioPharma, Inc. has an extensive intellectual property portfolio consisting of granted patents, published applications and pending applications.

March 16, 2022
·
4 min read
Business

C4 Therapeutics Appoints Utpal Koppikar to Board of Directors

C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of small-molecule medicines and transform how disease is treated, announced the appointment of Utpal Koppikar, MBA, to its board of directors.

March 16, 2022
·
5 min read
Business

Eton Pharmaceuticals Reports Fourth Quarter 2021 Financial Results

Eton Pharmaceuticals, Inc, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, reported financial results for the fourth quarter ended December 31, 2021.

March 16, 2022
·
12 min read
Genetown

Stealth BioTherapeutics Showcases New Duchenne Muscular Dystrophy Nonclinical Data at the 2022 Muscular Dystrophy Association and Clinical and Scientific Conference

Stealth BioTherapeutics Corp (Nasdaq:MITO), today presented new data demonstrating the potential synergistic relationship between elamipretide and an exon skipping phosphorodiamidate morpholino oligomer (PMO) in the X-linked muscular dystrophy (mdx) mouse model.

March 16, 2022
·
5 min read
Business

Akumin Announces Fourth Quarter 2021 Results

Akumin Inc., a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service line needs, announced its financial results for the quarter and year ended December 31, 2021.

March 16, 2022
·
11 min read